A first in-human phase 1 trial of BLU-5937 for chronic cough in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2018
At a glance
- Drugs BLU-5937 (Primary)
- Indications Cough
- Focus Adverse reactions; First in man; Pharmacokinetics
- 27 Jun 2018 According to a BELLUS Health media release, the study is expected to initiate in July 2018, with results expected in the fourth quarter of 2018.
- 21 Feb 2018 According to a BELLUS Health media release, company expects to start this trial in third quarter of 2018 and expects top line data by year-end.
- 08 Nov 2017 According to a BELLUS Health media release, the company is planning file a Clinical Trial Application in the second quarter of 2018 and initiate this trial in the third quarter of 2018.